维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Mahankali A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The effect of pioglitazone on the liver:role of adiponectin显示文摘	GASTALDELLI A MIYAZAKI Y MAHANKALI A	2006	Diabetes Care2006，29，10：	1
2	Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients显示文摘	Miyazaki Y Mahankali A Matsuda M	2002	J Clin Endocrinol Metab2002，87，6：	1
3	Reduction in hematocrit and hemoglobin following Pioglitazone treatment is not hemodilutional in Type II Diabetes Mellitus 显示文摘	Berrial R Glass L Mahankali A	2007	Clinical Pharmacology & Therapeutics2007，82，3：	1
4	Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone显示文摘	Miyazaki Y Mahankali A Matsuda M	2001	Diabetes Care2001，24，71：	1
5	Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic sub- jects treated with pioglitazone 显示文摘	Miyazaki Y Mahankali A Matsuda M	2001	Diabetes Care2001，24，4：	1
6	Evidence for two CRIB domains in phospholipase D2 (PLD2) that the enzyme uses to specifically bind to the small GTPase Rac2 显示文摘	Peng HJ Henkels KM Mahankali M et a!	2011	Biochem J2011，286，16：	1
7	Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus显示文摘	Miyazaki Y Mahankali A Matsuda M	2000	Diabetes2000，49，1：	1
8	Effect of piglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients显示文摘	Miyazaki Y Mahankali A Matsuda M		0，，06：	1
9	Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglita zone显示文摘	Miyazaki Y Mahankali A Matsuda M	2001	Diabetes Care2001，24，：	1
10	Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglita zone显示文摘	Miyazaki Y Mahankali A Matsuda M	2001	Diabetes Care2001，24，：	1
11	Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in type Ⅱ diabetes mellitus显示文摘	Berria R Glass L Mahankali A	2007	Clin Pharmacol Ther2007，82，3：	1
12	Effect of pioglita- zone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients 显示文摘	Miyazaki Y Mahankali A Matsuda M	2002	J Clin Endocrinol Metab2002，87，6：	1
13	Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone显示文摘	Miyazakli Y Mahankali A Matsuda M	2001	Diabetes Care2001，24，4：	1
14	Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients 显示文摘	Miyazaki Y Mahankali A Matsuda M	2002	J Clin Endocrinol Metab2002，87，6：	1
15	Reduction in hematocrit and hemoglo- bin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus 显示文摘	Berriai R Glass L Mahankali A	2007	Clinical Clin Pharmacol Ther2007，82，3：	1
16	Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients 显示文摘	Miyazaki Y Mahankali A Wajeberg E	2004	J Clin Endocrinol Metab2004，89，9：	1
17	Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients 显示文摘	MIYAZAKI Y MAHANKALI A MATSUDA M	2002	J Clin Endocrinol Metab2002，87，：	1
18	Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients显示文摘	Miyazaki Y Mahankali A Matsuda M		0，，：	1
19	Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients显示文摘	Miyazaki Y Mahankali A Wajcberg E	2004	Journal of Clinical Endocrinology and Metabolism2004，89，9：	1
20	Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone显示文摘	MIYAZAKI Y MAHANKALI A MATSUDA M	2001	Diabetes Care2001，24，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示